ALSERES Pharmaceuticals, Inc.
85 Main Street
Hopkinton
Massachusetts
01748
United States
Tel: 508-497-2360
Fax: 508-497-9964
Website: http://www.alseres.com/
Email: IR@bostonlifesciences.com
43 articles about ALSERES Pharmaceuticals, Inc.
-
ALSERES Pharmaceuticals, Inc. Reports License of Altropane® Worldwide Rights to Navidea Biopharmaceuticals
8/1/2012
-
Delisting of Securities of ALSERES Pharmaceuticals, Inc. From The NASDAQ Stock Market
7/17/2009
-
ALSERES Pharmaceuticals, Inc. Shares Begin Trading on the Pink Sheets OTC Market
5/8/2009
-
ALSERES Pharmaceuticals, Inc. and BioAxone Therapeutic Inc. Amend License Agreement for Cethrin(R) and Rho Inhibitor Technology
4/30/2009
-
ALSERES Pharmaceuticals, Inc. Receives Notice of De-Listing of Its Securities for Failure to Regain Compliance with Continued Listing Requirements
4/14/2009
-
ALSERES Pharmaceuticals, Inc. Receives Special Protocol Assessment Agreement from FDA for Phase III Trial of Altropane
4/7/2009
-
ALSERES Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K
4/1/2009
-
ALSERES Pharmaceuticals, Inc. Reports 2008 Results
3/26/2009
-
ALSERES Pharmaceuticals, Inc. Announces $200,000 Financing
2/27/2009
-
ALSERES Pharmaceuticals, Inc. Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program
2/3/2009
-
ALSERES Pharmaceuticals, Inc. Announces $1 Million Financing
1/13/2009
-
Massachusetts Biotechnology Council, Inc. Release: 19 Biotech Companies Selected to Present at 10th Annual MassBio Investors Forum
12/2/2008
-
ALSERES Pharmaceuticals, Inc. Announces $1 Million Financing
11/21/2008
-
ALSERES Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results Conference Call To Be Held Friday, November 14, 2008 at 9:00 a.m. Eastern Time
11/14/2008
-
ALSERES Pharmaceuticals, Inc. To Host Third Quarter 2008 Conference Call
11/10/2008
-
The European Commission Grants Orphan Drug Designation to ALSERES Pharmaceuticals, Inc.'s Spinal Cord Injury Treatment, Cethrin(R)
9/18/2008
-
ALSERES Pharmaceuticals, Inc. Announces Preclinical Study Results Demonstrating that Rho Inhibitors Could Be Useful in Promoting Bone Healing
8/28/2008
-
ALSERES Pharmaceuticals, Inc. Consolidates Its Offices and Moves into New Headquarters
8/19/2008
-
ALSERES Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results
8/14/2008
-
ALSERES Pharmaceuticals, Inc. Raises $5 Million
6/30/2008